Sparrow Hospital is a 733-bed teaching hospital located in Lansing, Michigan that provides care for the greater Mid-Michigan region. The hospital is a subsidiary of Sparrow Health System, and is affiliated with the Colleges of Human Medicine and Osteopathic Medicine at nearby Michigan State University.

There are 845 beds in Sparrow Hospital.

During the past decade, Sparrow Hospital conducted 185 clinical trials. In the 10-year time frame, 185 clinical trials started and 170 clinical trials were completed, i.e. on average, 91.9% percent of trials that started reached the finish line to date. In the past 5 years, 74 clinical trials started and 90 clinical trials were completed. i.e. 121.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sparrow Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 174 trials, followed by "SWOG Cancer Research Network" with 43 trials sponsored, "Alliance for Clinical Trials in Oncology" with 36 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 17 trials sponsored and "Gynecologic Oncology Group" with 17 trials sponsored. Other sponsors include 61 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sparrow Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 132 trials as a collaborator, "NRG Oncology" with 44 trials as a collaborator, "Canadian Cancer Trials Group" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "Genentech, Inc." with 6 trials as a collaborator. Other collaborators include 84 different institutions and companies that were collaborators in the rest 60 trials.

According to Clinical.Site data, the most researched conditions in "Sparrow Hospital" are "Recurrent Ovarian Carcinoma" (13 trials), "Stage IV Lung Cancer AJCC v8" (12 trials), "Fallopian Tube Transitional Cell Carcinoma" (11 trials), "Recurrent Breast Carcinoma" (11 trials) and "Breast Cancer" (10 trials). Many other conditions were trialed in "Sparrow Hospital" in a lesser frequency.

Most popular intervention types in "Sparrow Hospital" are "Drug" (278 trials), "Other" (199 trials), "Biological" (125 trials), "Procedure" (66 trials) and "Radiation" (46 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (110 trials), "Quality-of-Life Assessment" (80 trials), "Paclitaxel" (47 trials), "Questionnaire Administration" (44 trials) and "Carboplatin" (40 trials). Other intervention names were less common.

The vast majority of trials in "Sparrow Hospital" are 265 trials for "All" genders, 67 trials for "Female" genders and 15 trials for "Male" genders.

Currently, there are NaN active trials in "Sparrow Hospital". undefined are not yet recruiting, 68 are recruiting, 134 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 109 completed trials in Sparrow Hospital, 7 suspended trials, and 26 terminated clinical trials to date.

Out of the total trials that were conducted in Sparrow Hospital, 12 "Phase 1" clinical trials were conducted, 173 "Phase 2" clinical trials and 158 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 15 trials that are defined as “Not Applicable".

Sparrow Hospital has several departments that took part in Clinical trials: "Sparrow Regional Cancer Center" - 177 trials, "Sparrow Clinical Research Institute" - 53 trials, "Thoracic Cardiovascular Healthcare Foundation" - 22 trials, "Thoracic and Cardiovascular Institute" - 9 trials, "Herbert-Herman Cancer Center, Sparrow Hospital" - 4 trials